NASDAQ: CRDL - Cardiol Therapeutics Inc.

Altı ay boyunca karlılık: -31.77%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Cardiol Therapeutics Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis.

daha fazla ayrıntı
The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2019-01-15
ISIN CA14161Y2006
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cad
Сайт https://www.cardiolrx.com
Цена ао 1.95
Günlük fiyat değişimi: -0.7576% (1.32)
Haftalık fiyat değişimi: +2.34% (1.28)
Aylık fiyat değişimi: -17.09% (1.58)
3 ayda fiyat değişimi: -36.71% (2.07)
Altı ayda fiyat değişimi: -31.77% (1.92)
Yıllık fiyat değişimi: +55.4% (0.843)
3 yılda fiyat değişimi: -32.82% (1.95)
5 yılda fiyat değişimi: -55.58% (2.949)
10 yılda fiyat değişimi: 0% (1.31)
Yılbaşından bu yana fiyat değişimi: -14.38% (1.53)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV 2.51 6
P/E 0 0
EV/EBITDA -1.23 0
Toplam: 3.25

Yeterlik

İsim Anlam Seviye
ROA, % -76.64 0
ROE, % -99.58 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.0059 10
Toplam: 9.6

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % 120.28 10
karlılık EPS, % 6.4 1
Toplam: 4.2
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
MMCAP International, Inc. SPC 2953300 4.33
AdvisorShares Investments, LLC 1189978 1.75
Tejara Capital Ltd 1116676 1.64
AXS Investments, LLC 697651 1.02
Lion Street Advisors, LLC 192700 0.28
Bank of Montreal/Can/ 104479 0.15
We Are One Seven, LLC 100000 0.15
Laird Norton Trust Company, LLC 100000 0.15
Cambridge Investment Research Advisors Inc. 85201 0.12
Credit Suisse Ag/ 80000 0.12

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
AdvisorShares Pure Cannabis ETF 6.51027 -3.73 1.68573



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. David G. Elsley MBA President, CEO & Director 550.14k
Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA CFO, Corporate Secretary & Director 216.79k
Mr. Bernard Lim B.Sc. Chief Operating Officer 379.39k
Dr. Andrew Warwick Hamer M.D. Chief Medical Officer & Head of Research & Development 549.01k 1962 (63 yıl)
Trevor Burns Investor Relations N/A
Mr. John A. Geddes BSCPT, MBA Vice President of Corporate Development

Adres: Canada, Oakville, 2265 Upper Middle Road East - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.cardiolrx.com